Proacta S.A. (WSE:PAC)
Poland · Delayed Price · Currency is PLN 1.610
+0.040 (2.55%)
At close: Oct 14, 2026
Proacta Revenue
Proacta had revenue of 6.17M PLN in the quarter ending March 31, 2026, with 453.66% growth. This brings the company's revenue in the last twelve months to 17.69M, up 363.96% year-over-year. In the year 2025, Proacta had annual revenue of 12.64M with 193.93% growth. That makes Proacta the 41,504th largest company in the world by revenue and 426th in Poland.
Revenue (ttm)
17.69M
Revenue Growth
+363.96%
P/S Ratio
16.07
Revenue / Employee
754.85K
Employees
15
Market Cap
182.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.64M | 8.34M | 193.93% |
| Dec 31, 2024 | 4.30M | 3.65M | 563.71% |
| Dec 31, 2023 | 647.67K | -630.06K | -49.31% |
| Dec 31, 2022 | 1.28M | -168.04K | -11.62% |
| Dec 31, 2019 | 1.45M | 1.03M | 246.42% |
| Dec 31, 2018 | 417.35K | -445.09K | -51.61% |
| Dec 31, 2017 | 862.44K | 474.80K | 122.49% |
| Dec 31, 2016 | 387.64K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Euvic | 522.70M |
| Mineral Midrange | 15.93M |
| Sigma Defence | 5.45M |
| Munar Pharma | 250.00K |
| BTC Studios | 38.00K |
| W.G Partners | -1.22M |